BENTSUR RON (Chairman & CEO) purchased 0.3% of their position (12.50K shares) of NUVECTIS PHARMA, INC. on the open market
Open‑market purchase worth $250.0K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 7/1/2026ACC: 0001104659-26-079792
DirectorOfficer· Chairman & CEO
Since Feb 2022
+12.50K
Net shares
Net buyer
$250.0K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
12.50K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+12.50K
Price / share
$20.00
Trade value
$250K
% of position
0.3%
6/30/2026
3.68M→3.69M
Total
Net shares
+12.50K
Net value
$250K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/30/2026 | P · Purchase | +12.50K | $20.00 | $250K | 0.3% | 3.68M | 3.69M |
| Total | +12.50K | $250K | ||||||
Derivative Transactions0
No derivative transactions reported